Costs of Audit. If Company’s royalties calculated for any calendar year quarterly period are under-reported by more than 5%, the costs of any audit and review initiated by University will be borne by Company; otherwise, University shall bear the costs of any audit initiated by University.
Costs of Audit. The inspection referred to in this Section 6 shall be conducted at Licensing Company’s own expense, except that such expense shall be borne by Licensee where the inspection reveals that:
Costs of Audit. The SPF Manager shall pay on behalf of Participating Insurers the costs and expenses of the Law Society in respect of any Risk Management Audit and any related costs that are imposed on an ARP Firm, a Run-off Firm, any Firm which has other coverage arranged by the SPF Manager pursuant to paragraph 2.12 or cover arranged by the SPF Manager through the ROF under Regulation 6(a) of the Regulations and/or in accordance with paragraphs 2.13 or 2.14 or on any Firm in respect of which a Risk Management Audit has been conducted as notified to the SPF Manager by the Law Society. The SPF Manager shall be entitled to seek reimbursement of any such costs and expenses from the relevant Firm.
Costs of Audit. If Company’s payments calculated for any calendar quarter are under- reported by more than [***], the costs of any audit and review initiated by University will be borne by Company; otherwise, University shall bear the costs of any audit initiated by University.
Costs of Audit. (a) All costs incurred by you in connection with the Audits contemplated in section 1 will remain solely your responsibility.
Costs of Audit. The Parties will bear their own costs and expenses incurred in respect of compliance with their obligations under this clause 11, unless the audit under clause 11.1 identifies any significant non-compliance with this Agreement by the Supplier, in which case and without prejudice to any other rights or remedies HBDHB has under this Agreement or otherwise at Law, the Supplier will reimburse HBDHB for all its reasonable costs incurred in the course of the audit.
Costs of Audit. Each party will bear its own costs in relation to any such access, inspection, copying, observation, interviewing, testing or audit unless any significant breach of this agreement by EQC is revealed in which case EQC will meet the reasonable costs of Southern Response and its reinsurers in relation to any such access, inspection, copying, observation, interviewing, testing and audit.
Costs of Audit. If an audit, inspection or examination of Xxxxxx’s performance discloses underpayments (or other adjustments in favor of Lessor) of any nature in excess of three percent (3%) of any payments or single payment. Lessee shall pay to Lessor Lessor’s actual cost (based on the amount paid by Lessor, or based on reasonable charges charged by private auditors and other service providers for comparable work if the audit is performed by Lessor’s employees) of the audit, inspection or examination, together with late fees, interest, and other amount payable in connection with such adjustments or payments. Any adjustments and/or payments which must be made as a result of any such audit, inspection or examination (whether or not performed in- house by Lessor), shall be made within a reasonable amount of time (not to exceed 30 days) after Lessor gives toXessee notice of Lessor’s findings.
Costs of Audit. If Company’s royalties calculated for any calendar year quarterly period are under-reported by more than 3%, the costs of any audit and review initiated by HSI will be borne by Company; otherwise, HSI shall bear the costs of any audit initiated by HSI.
Costs of Audit. Aspreva shall bear the cost of any audit under this Section 8.13, except in the event that the results of the audit reveal an underpayment of the amounts described in this Article 8 by [ * ] or more over the period being audited, in which case Roche shall pay all costs of such examination. In the event that such examination concludes that additional amounts are owed to Aspreva, Roche shall pay any such additional amounts within thirty (30) days of the date that Roche receives the written report so concluding. In the event that such examination concludes that there has been an overpayment with respect to amounts paid to Aspreva, the excess (after deducting the cost of the examination) shall be credited to Roche against future payments required by this Article 8.
